| For: | Chawla T, Sharma D, Singh A. Role of the renin angiotensin system in diabetic nephropathy. World J Diabetes 2010; 1(5): 141-145 [PMID: 21537441 DOI: 10.4239/wjd.v1.i5.141] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v1/i5/141.htm |
| Number | Citing Articles |
| 1 |
Tamil Selvi Loganathan, Siti Aishah Sulaiman, Nor Azian Abdul Murad, Shamsul Azhar Shah, Abdul Halim Abdul Gafor, Rahman Jamal, Noraidatulakma Abdullah. Interactions Among Non-Coding RNAs in Diabetic Nephropathy. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00191
|
| 2 |
Farideh Razi, Maryam Sadat Daneshpour, Mostafa Karimoei, Mohsen Mehrabzadeh, Fatemeh Bandarian, Elham Bahreini, Mostafa Qorbani, Parvin Pasalar. AGTR1 rs5186 variants in patients with type 2 diabetes mellitus and nephropathy. Meta Gene 2018; 15 doi: 10.1016/j.mgene.2017.11.001
|
| 3 |
Ini-Isabée Witzel, Herbert F. Jelinek, Kinda Khalaf, Sungmun Lee, Ahsan H. Khandoker, Habiba Alsafar. Identifying Common Genetic Risk Factors of Diabetic Neuropathies. Frontiers in Endocrinology 2015; 6 doi: 10.3389/fendo.2015.00088
|
| 4 |
Vinicius Guzzoni, Isabel Cristina Mallosto Emerich de Abreu, Mariane Bertagnolli, Roberta Hack Mendes, Adriane Belló-Klein, Dulce Elena Casarini, Karin Flues, Geórgia Orsi Cândido, Janaína Paulini, Kátia De Angelis, Fernanda Klein Marcondes, Maria Cláudia Irigoyen, Tatiana Sousa Cunha. Aerobic training increases renal antioxidant defence and reduces angiotensin II levels, mitigating the high mortality in SHR-STZ model. Archives of Physiology and Biochemistry 2024; 130(6) doi: 10.1080/13813455.2024.2377381
|
| 5 |
Danish Rizwan, F. A. Masoodi, Shoib Mohmad Wani, Sajad Ahmad Mir. Bioactive peptides from fermented foods and their relevance in COVID-19 mitigation. Food Production, Processing and Nutrition 2023; 5(1) doi: 10.1186/s43014-023-00165-w
|
| 6 |
M. Nascimento, G.R. Punaro, R.S. Serralha, D.Y. Lima, M.G. Mouro, L.C.G. Oliveira, D.E. Casarini, A.M. Rodrigues, E.M.S. Higa. Inhibition of the P2X7 receptor improves renal function via renin-angiotensin system and nitric oxide on diabetic nephropathy in rats. Life Sciences 2020; 251 doi: 10.1016/j.lfs.2020.117640
|
| 7 |
Kalpana Sen, Trilochan Satapathy. Efficient and Safe Induction of Diabetes in Experimental Animals: A Review on Alternative Models and Techniques. Journal of Lab Animal Research 2024; 3(5) doi: 10.58803/jlar.v3i5.47
|
| 8 |
Bhanu Sharma, Tahir Hussain, Mohammed A. Khan, Varun Jaiswal . Exploring AT2R and its Polymorphism in Different Diseases: An Approach
to Develop AT2R as a Drug Target beyond Hypertension. Current Drug Targets 2022; 23(1) doi: 10.2174/1389450122666210806125919
|
| 9 |
Yuye Zhu, Chunying Liu, Jamal Hallajzadeh. Understanding the Roles of Non-coding RNAs and Exosomal Non-Coding RNAs in Diabetic Nephropathy. Current Molecular Medicine 2025; 25(5) doi: 10.2174/0115665240287631240321072504
|
| 10 |
Daria V. Ilatovskaya, Gregory Blass, Oleg Palygin, Vladislav Levchenko, Tengis S. Pavlov, Michael N. Grzybowski, Kristen Winsor, Leonid S. Shuyskiy, Aron M. Geurts, Allen W. Cowley, Lutz Birnbaumer, Alexander Staruschenko. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease. Journal of the American Society of Nephrology 2018; 29(7) doi: 10.1681/ASN.2018030280
|
| 11 |
Esam S. B. Salem, Nadja Grobe, Khalid M. Elased. Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. American Journal of Physiology-Renal Physiology 2014; 306(6) doi: 10.1152/ajprenal.00516.2013
|
| 12 |
Chanawee Hirunpattarasilp, David Attwell, Felipe Freitas. The role of pericytes in brain disorders: from the periphery to the brain. Journal of Neurochemistry 2019; 150(6) doi: 10.1111/jnc.14725
|
| 13 |
John P. Kirwan, Elizabeth C. Heintz, Candida J. Rebello, Christopher L. Axelrod. Exercise in the Prevention and Treatment of Type 2 Diabetes. Comprehensive Physiology 2023; 13(2) doi: 10.1002/j.2040-4603.2023.tb00259.x
|
| 14 |
Eman A. Elbassuoni, Neven M. Aziz, Nashwa F. El-Tahawy. Protective effect of C-peptide on experimentally induced diabetic nephropathy and the possible link between C-peptide and nitric oxide. Applied Physiology, Nutrition, and Metabolism 2018; 43(6) doi: 10.1139/apnm-2017-0617
|
| 15 |
Anubhav Kumar Singh, Niraj Kumar Singh, Ahsas Goyal, Bhupesh Chander Semwal, Harlokesh Narayan Yadav. Role of Brain Angiotensin-II in Development of Experimental Diabetic Nephropathy in Wistar Rats. Brazilian Journal of Pharmaceutical Sciences 2023; 59 doi: 10.1590/s2175-97902023e20200
|
| 16 |
Khaled K. Al-Qattan, Martha Thomson, Muslim Ali. Garlic extract increases non-clipped kidney tubular natriuresis and diuresis in the 2-kidney, 1-clip rat model: Significance in hypertension. Pathophysiology 2017; 24(4) doi: 10.1016/j.pathophys.2017.08.004
|
| 17 |
Andréa E.M. Stinghen, Ziad A. Massy, Helen Vlassara, Gary E. Striker, Agnès Boullier. Uremic Toxicity of Advanced Glycation End Products in CKD. Journal of the American Society of Nephrology 2016; 27(2) doi: 10.1681/ASN.2014101047
|
| 18 |
Duygu Sari-Ak, Fatih Con, Nazli Helvaci, Hayriye Ecem Yelkenci, Alev Kural, Ozgur Can, Mustafa Caglar Beker. Exploring the Proteomic Signature of Diabetic Nephropathy: Implications for Early Diagnosis and Treatment. Life 2025; 15(8) doi: 10.3390/life15081312
|
| 19 |
Khalilah M. McCants, Kathryn B. Reid, Ishan Williams, D. Elise Miller, Richard Rubin, Suzanne Dutton. The Impact of Case Management on Reducing Readmission for Patients Diagnosed With Heart Failure and Diabetes. Professional Case Management 2019; 24(4) doi: 10.1097/NCM.0000000000000359
|
| 20 |
Rodrigo P. Silva-Aguiar, Douglas E. Teixeira, Rodrigo A. S. Peres, Diogo B. Peruchetti, Carlos P. Gomes, Alvin H. Schmaier, Patricia R. M. Rocco, Ana Acacia S. Pinheiro, Celso Caruso-Neves. Subclinical Acute Kidney Injury in COVID-19: Possible Mechanisms and Future Perspectives. International Journal of Molecular Sciences 2022; 23(22) doi: 10.3390/ijms232214193
|
| 21 |
Nur Samsu, Maria Irene Bellini. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/1497449
|
| 22 |
Yuying Wang, Wen Peng, Xiaoxue Zhang, Huibo Qiao, Li Wang, Zhigang Xu, Chenguang Wu. The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan. Journal of the Renin-Angiotensin-Aldosterone System 2016; 17(3) doi: 10.1177/1470320316666749
|
| 23 |
Farzaneh Karimi, Maryam Maleki, Ahmad Movahedpour, Mehdi Alizadeh, Ebrahim Kharazinejad, Mohammad Sabaghan. Overview of the renin-angiotensin system in diabetic nephropathy. Journal of the Renin-Angiotensin-Aldosterone System 2024; 25 doi: 10.1177/14703203241302966
|
| 24 |
Leyu Huang, Hui Li, Ying Han. Exploring the mechanism of Epimedium in treating diabetic nephropathy based on network pharmacology and experimental validation study. Cytotechnology 2025; 77(3) doi: 10.1007/s10616-025-00748-0
|
| 25 |
Min Zheng, Lin-Li Lv, Yu-Han Cao, Hong Liu, Jie Ni, Hou-Yong Dai, Dan Liu, Xiang-Dong Lei, Bi-Cheng Liu, John E. Mendelson. A Pilot Trial Assessing Urinary Gene Expression Profiling with an mRNA Array for Diabetic Nephropathy. PLoS ONE 2012; 7(5) doi: 10.1371/journal.pone.0034824
|
| 26 |
Peter Austin Morton Ntenda, Walaa Mamdouh Reyad El-Meidany, Fentanesh Nibret Tiruneh, Mfundi President Sebenele Motsa, Joyce Nyirongo, Gowokani Chijere Chirwa, Arnold Kapachika, Owen Nkoka. Determinants of self-reported hypertension among women in South Africa: evidence from the population-based survey. Clinical Hypertension 2022; 28(1) doi: 10.1186/s40885-022-00222-5
|
| 27 |
Marlena Typiak, Agnieszka Piwkowska. Various effects of ADAM10 and ADAM17 metalloproteases on kidney (dys)function. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2026; 1872(8) doi: 10.1016/j.bbadis.2026.168380
|
| 28 |
Dante Amato, Alma R. Núñez-Ortiz, José del Carmen Benítez-Flores, David Segura-Cobos, Pedro López-Sánchez, Beatriz Vázquez-Cruz. Role of Angiotensin-(1-7) on Renal Hypertrophy in Streptozotocin-Induced Diabetes Mellitus. Pharmacology & Pharmacy 2016; 7(09) doi: 10.4236/pp.2016.79046
|
| 29 |
Zohreh Rahimi. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. Journal of Nephropathology 2012; 1(3) doi: 10.5812/nephropathol.8109
|
| 30 |
Chao Zheng, Lan Huang, Wu Luo, Weihui Yu, Xueting Hu, Xinfu Guan, Yan Cai, Chunpeng Zou, Haimin Yin, Zheng Xu, Guang Liang, Yi Wang. Inhibition of STAT3 in tubular epithelial cells prevents kidney fibrosis and nephropathy in STZ-induced diabetic mice. Cell Death & Disease 2019; 10(11) doi: 10.1038/s41419-019-2085-0
|
| 31 |
Laetitia Jacquot, Océane Pointeau, Célia Roger-Villeboeuf, Patricia Passilly-Degrace, Rim Belkaid, Isaline Regazzoni, Julia Leemput, Chloé Buch, Laurent Demizieux, Bruno Vergès, Pascal Degrace, Glenn Crater, Tony Jourdan. Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy. Frontiers in Nephrology 2023; 3 doi: 10.3389/fneph.2023.1138416
|
| 32 |
Cristina Mega, Edite Teixeira de Lemos, Helena Vala, Rosa Fernandes, Jorge Oliveira, Filipa Mascarenhas-Melo, Frederico Teixeira, Flávio Reis. Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat). Experimental Diabetes Research 2011; 2011 doi: 10.1155/2011/162092
|
| 33 |
Yiwei Zhang, Shelya X. Zeng, Qian Hao, Hua Lu. Monitoring p53 by MDM2 and MDMX is required for endocrine pancreas development and function in a spatio-temporal manner. Developmental Biology 2017; 423(1) doi: 10.1016/j.ydbio.2017.01.014
|
| 34 |
Zhi-Cheng Dai, Jin-Xia Chen, Rong Zou, Xuan-Bing Liang, Ji-Xin Tang, Cui-Wei Yao. Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1213473
|
| 35 |
Sreenithya Ravindran, Shankar Munusamy. Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease. Journal of Cellular Physiology 2022; 237(2) doi: 10.1002/jcp.30621
|
| 36 |
Zhao Dong, Chang Xun Chen. Effect of catalpol on diabetic nephropathy in rats. Phytomedicine 2013; 20(11) doi: 10.1016/j.phymed.2013.04.007
|
| 37 |
Anil Kumar Pasupulati, P. Swathi Chitra, G. Bhanuprakash Reddy. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomolecular Concepts 2016; 7(5-6) doi: 10.1515/bmc-2016-0021
|
| 38 |
Faeq Husain-Syed, Goekhan Yuecel, Clara Daschner, Jan Jochims, Babak Yazdani. Therapeutic Advances in Diabetic Kidney Disease: 30 Years of Evidence and the Rise of the “Fantastic Four” in Nephrology. Cardiorenal Medicine 2026; 16(1) doi: 10.1159/000550423
|
| 39 |
Hooria Younas, Tahira Ijaz, Nakhshab Choudhry, Kanhaiya Singh. Investigation of angiotensin-1 converting enzyme 2 gene (G8790A) polymorphism in patients of type 2 diabetes mellitus with diabetic nephropathy in Pakistani population. PLOS ONE 2022; 17(2) doi: 10.1371/journal.pone.0264038
|
| 40 |
Merve ARAS, Özlem YAYINTAŞ. Şeker hastalığı üzerinde quercetin, gallik asit, oleanolik asit ve ursolik asitin in siliko analizi. Troia Medical Journal 2022; doi: 10.55665/troiamedj.1163784
|
| 41 |
Amal F. Dawood, Amro Maarouf, Norah M. Alzamil, Maha A. Momenah, Ayed A. Shati, Nervana M. Bayoumy, Samaa S. Kamar, Mohamed A. Haidara, Asmaa M. ShamsEldeen, Hanaa Z. Yassin, Peter W. Hewett, Bahjat Al-Ani. Metformin Is Associated with the Inhibition of Renal Artery AT1R/ET-1/iNOS Axis in a Rat Model of Diabetic Nephropathy with Suppression of Inflammation and Oxidative Stress and Kidney Injury. Biomedicines 2022; 10(7) doi: 10.3390/biomedicines10071644
|
| 42 |
Temitope Isaac Adelusi, Lei Du, Meng Hao, Xueyan Zhou, Qian Xuan, Chowdhury Apu, Ying Sun, Qian Lu, Xiaoxing Yin. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy. Biomedicine & Pharmacotherapy 2020; 123 doi: 10.1016/j.biopha.2019.109732
|
| 43 |
Aman Singh, Krishna Singh. Renin-Angiotensin-Aldosterone System - Latest Trends. 2024; doi: 10.5772/intechopen.1007937
|
| 44 |
Sourabh Sharma, Sanjay Kalra. Gluconephrotic Syndrome: A Comprehensive Review. Journal of The Association of Physicians of India 2024; 72(10) doi: 10.59556/japi.72.0687
|
| 45 |
Mohamed E. Elrggal, Ahmed Elkeraie, Sol Carriazo, Hany Sawaf, Si Yuan Khor, Yasmine Elkeraie, Issa Haddad, Khaled Moustafa, Mohamed Hassanein. Frontiers in Clinical Drug Research-Diabetes and Obesity: Volume 7. Frontiers in Clinical Drug Research-Diabetes and Obesity 2023; 7 doi: 10.2174/9789815123586123070009
|
| 46 |
Carmen-Antonia Mocanu, Tudor Petrisor Simionescu, Andreea Elena Mocanu, Liliana Garneata. Plant-Based versus Animal-Based Low Protein Diets in the Management of Chronic Kidney Disease. Nutrients 2021; 13(11) doi: 10.3390/nu13113721
|
| 47 |
Rakhi Chakraborty, Swarnendu Roy. Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. Journal of Integrative Medicine 2021; 19(6) doi: 10.1016/j.joim.2021.09.006
|
| 48 |
Ana Paula Vieira Pontes Vaz Gontijo, Priscila Magalhães Esteves de Sales. Nefropatia Diabética: Fisiopatologia, Diagnóstico e Tratamento. Saúde Coletiva (Barueri) 2025; 16(100) doi: 10.36489/saudecoletiva.2025v16i100p17266-17275
|
| 49 |
Akinjide Moses Akinnuga, Angezwa Siboto, Bongiwe Khumalo, Ntethelelo Hopewell Sibiya, Phikelelani Ngubane, Andile Khathi. Ameliorative Effects of Bredemolic Acid on Markers Associated with Renal Dysfunction in a Diet-Induced Prediabetic Rat Model. Oxidative Medicine and Cellular Longevity 2020; 2020 doi: 10.1155/2020/2978340
|
| 50 |
Jiarong Lv, Yu Wu, Yifeng Mai, Shizhong Bu. Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy. Journal of Diabetes Research 2020; 2020 doi: 10.1155/2020/3960857
|
| 51 |
Paola Pontrelli, Francesca Conserva, Rossella Menghini, Michele Rossini, Alessandra Stasi, Chiara Divella, Viviana Casagrande, Claudia Cinefra, Mariagrazia Barozzino, Simona Simone, Francesco Pesce, Giuseppe Castellano, Giovanni Stallone, Anna Gallone, Francesco Giorgino, Massimo Federici, Loreto Gesualdo. Inhibition of Lysine 63 Ubiquitination Prevents the Progression of Renal Fibrosis in Diabetic DBA/2J Mice. International Journal of Molecular Sciences 2021; 22(10) doi: 10.3390/ijms22105194
|
| 52 |
Sarfaraz Ahmad, Kendra N. Wright, Jessica L. VonCannon, Carlos M. Ferrario, Mohammad S. Ola, Mayur Choudhary, Goldis Malek, Jenna R. Gustafson, Rebecca M. Sappington. Internalization of Angiotensin-(1–12) in Adult Retinal Pigment Epithelial-19 Cells. Journal of Ocular Pharmacology and Therapeutics 2023; 39(4) doi: 10.1089/jop.2022.0139
|
| 53 |
Lindokuhle Patience Mabuza, Mlindeli Wilkinson Gamede, Sanam Maikoo, Irvin Noel Booysen, Phikelelani Siphosethu Ngubane, Andile Khathi. Amelioration of risk factors associated with diabetic nephropathy in diet-induced pre-diabetic rats by an uracil-derived diimine ruthenium(II) compound. Biomedicine & Pharmacotherapy 2020; 129 doi: 10.1016/j.biopha.2020.110483
|
| 54 |
Jaehyun Bae, Byung-Wan Lee. Significance of Diabetic Kidney Disease Biomarkers in Predicting Metabolic-Associated Fatty Liver Disease. Biomedicines 2023; 11(7) doi: 10.3390/biomedicines11071928
|
| 55 |
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, Andrzej Pawlik. Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus. International Journal of Molecular Sciences 2024; 25(9) doi: 10.3390/ijms25095027
|
| 56 |
Krit Jaikumkao, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn C. Chattipakorn, Nipon Chattipakorn, Anusorn Lungkaphin. The roles of sodium-glucose cotransporter 2 inhibitors in preventing kidney injury in diabetes. Biomedicine & Pharmacotherapy 2017; 94 doi: 10.1016/j.biopha.2017.07.095
|
| 57 |
Momina Shahid, Kanwal Rehman, Muhammad Sajid Hamid Akash, Shaleem Suhail, Shagufta Kamal, Muhammad Imran, Mohammed A. Assiri. Genetic Polymorphism in Angiotensinogen and Its Association with Cardiometabolic Diseases. Metabolites 2022; 12(12) doi: 10.3390/metabo12121291
|
| 58 |
Prem Patel, Jessica Ammon, Sean Battle, Donald J. DiPette. The Moreton Lecture Series: The Renin-Angiotensin-Aldosterone System—Physiology, Pathophysiology, and Pharmacological Inhibition. Southern Medical Journal 2025; 118(1) doi: 10.14423/SMJ.0000000000001775
|
| 59 |
Zorita Diaconeasa, Georgiana Dretcanu, Daria T. Pop, Bianca Enaru. Advancement of Phenolic Acids in Drug Discovery. 2024; doi: 10.1016/B978-0-443-18538-0.00010-X
|
| 60 |
Diana V. Ávila-Martínez, Wendy K. Mixtega-Ruiz, José M. Hurtado-Capetillo, Oscar Lopez-Franco, Mónica Flores-Muñoz. Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1377113
|
| 61 |
Akiko Fujita, Keigyou Yoh, Homare Shimohata, Naoki Morito, Masami Ojima, Midori Okamura, Satoru Takahashi, Kunihiro Yamagata. A Novel Diabetes Mellitus Mouse Model, MAFA-Deficient and Beta Cell-Specific MAFK-Overexpressing Hybrid Transgenic Mice, Developed Severe Diabetic Nephropathy and Improved with TCV-116 (Candesartan Cilexetil) Treatment. Experimental Animals 2012; 61(1) doi: 10.1538/expanim.61.49
|
| 62 |
Langeswaran Kulanthaivel, Geevaprabhakaran Ganesan, Chandrashekar Kirubhanand, Gowtham Kumar Subbaraj. Advances in Diabetes Research and Management. 2023; doi: 10.1007/978-981-19-0027-3_5
|
| 63 |
Nehal M. Elsherbiny, Mohammed M.H. Al-Gayyar. The role of IL-18 in type 1 diabetic nephropathy: The problem and future treatment. Cytokine 2016; 81 doi: 10.1016/j.cyto.2016.01.014
|
| 64 |
A.G.M. Sofi Uddin Mahamud, Md. Ehsanul Kabir, Abdullah Al Mamun Sohag, Chong Chen, Md. Abdul Hannan, Mahmudul Hasan Sikder, Keshab Bhattarai, Bikash Baral, Md Jamal Uddin. Food-Derived Bioactive Peptides: A Promising Substitute to Chemosynthetic Drugs Against the Dysregulated Renin-Angiotensin System in COVID-19 Patients. Journal of Biologically Active Products from Nature 2021; 11(4) doi: 10.1080/22311866.2021.1945494
|
| 65 |
Brian Godman, Debashis Basu, Yogan Pillay, Julius C. Mwita, Godfrey Mutashambara Rwegerera, Bene D. Anand Paramadhas, Celda Tiroyakgosi, Patrick Mbah Okwen, Loveline Lum Niba, Justice Nonvignon, Israel Sefah, Margaret Oluka, Anastasia N. Guantai, Dan Kibuule, Francis Kalemeera, Mwangana Mubita, Joseph Fadare, Olayinka O. Ogunleye, Larry A. Distiller, Enos M. Rampamba, Jeffrey Wing, Debjani Mueller, Abubakr Alfadl, Adefolarin A. Amu, Zinhle Matsebula, Aubrey Kalungia, Trust Zaranyika, Nyasha Masuka, Janney Wale, Ruaraidh Hill, Amanj Kurdi, Angela Timoney, Stephen Campbell, Johanna C. Meyer. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00108
|
| 66 |
Amalan Venkatesan, Anitha Roy, Srinivasan Kulandaivel, Vijayakumar Natesan, Sung-Jin Kim. p-Coumaric Acid Nanoparticles Ameliorate Diabetic Nephropathy via Regulating mRNA Expression of KIM-1 and GLUT-2 in Streptozotocin-Induced Diabetic Rats. Metabolites 2022; 12(12) doi: 10.3390/metabo12121166
|
| 67 |
Ana Paula Vieira Pontes Vaz Gontijo, Priscila Magalhães Esteves de Sales. Nefropatia Diabética: Fisiopatologia, Diagnóstico e Tratamento. Saúde Coletiva (Barueri) 2025; 16(100) doi: 10.36489/saudecoletiva.2025v16i101p17266-17275
|
| 68 |
Xuan-Dien Le-Nguyen, Sy Van Hoang, Nam Tran. Association Between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Multicenter Case-Control Study in Vietnam. Diabetes, Metabolic Syndrome and Obesity 2026; doi: 10.2147/DMSO.S575757
|
| 69 |
Shivendra Kumar, Sunam Saha, Arockia Babu, Mohit Agrawal, Kuldeep Singh, Hema Chaudhary, Khushboo Lavania. Enzyme Inhibition in Managing Cardiovascular Diseases. Current Enzyme Inhibition 2024; 20(2) doi: 10.2174/0115734080275060231228093149
|
| 70 |
Marwa Akoul. Effect of Artemisia annua Extract on Kidney Functions and Histology in Experimental Diabetic Rats. Jurnal Biologi 2024; 2(1) doi: 10.47134/biology.v2i1.3316
|
| 71 |
Elahe Soltani-Fard, Sina Taghvimi, Farzaneh Karimi, Farzaneh Vahedi, Seyyed Hossein Khatami, Hamid Behrooj, Mojdeh Deylami Hayati, Ahmad Movahedpour, Hassan Ghasemi. Urinary biomarkers in diabetic nephropathy. Clinica Chimica Acta 2024; 561 doi: 10.1016/j.cca.2024.119762
|
| 72 |
Thangjam Surchandra Singh, Pintubala Kshetri, Asem Kajal Devi, Pangambam Langamba, Keishing Tamreihao, Heikham Naresh Singh, Romila Akoijam, Tania Chongtham, Chingakham Premabati Devi, Tensubam Basanta Singh, Sonia Chongtham, Yumnam Prabhabati Devi, Aparna Kuna, Soibam Giri Singh, Susheel Kumar Sharma, Anup Das, Subhra Saikat Roy. Bioactivity and nutritional quality of nutgall (Rhus semialata Murray), an underutilized fruit of Manipur. Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1133576
|
| 73 |
Pooja Joshi, Griffin Rick, Srihitha Mesineni, Sujan Bohara, Sehrish Atif, Nandakumar Poonthottam, Aiesha Azam, Yasir Mehmood, Ramsha Ali, Naama Raquib, Abhijith Sasikumar, Areeba Khalid, Onyekachi Emmanuel Anyagwa. Antihypertensive therapy in diabetes mellitus: efficacy, safety, and metabolic impacts in type 1 and type 2 diabetes. Cardiovascular Diabetology – Endocrinology Reports 2026; 12(1) doi: 10.1186/s40842-025-00268-y
|
| 74 |
Dan Wang, Cheng Wang, Xueqin Hao, Gabriela Carter, Rafaela Carter, William J. Welch, Christopher S. Wilcox. Activation of Nrf2 in Mice Causes Early Microvascular Cyclooxygenase-Dependent Oxidative Stress and Enhanced Contractility. Antioxidants 2022; 11(5) doi: 10.3390/antiox11050845
|
| 75 |
Yuqi Liu, Jiaqing Chen, Yangxin Huang. Predicting Hyperkalemia in Patients with Chronic Kidney Disease Using the CatBoost Model and Multiple Interpretability Analyses. Electronics 2026; 15(2) doi: 10.3390/electronics15020291
|
| 76 |
Qihan Zhao, Jingjing Li, Jun Yan, Shuai Liu, Yulin Guo, Dajie Chen, Qiong Luo. Lycium barbarum polysaccharides ameliorates renal injury and inflammatory reaction in alloxan-induced diabetic nephropathy rabbits. Life Sciences 2016; 157 doi: 10.1016/j.lfs.2016.05.045
|
| 77 |
Cristina Mega, Edite Teixeira-de-Lemos, Rosa Fernandes, Flávio Reis. Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes. Journal of Diabetes Research 2017; 2017 doi: 10.1155/2017/5164292
|
| 78 |
Simei Sun, Xiongyi Han, Liyan Bai, Myung Ho Jeong, Cheng Jin. Beyond β-Blockade: ACE Inhibitors Reduce Non-Cardiac Mortality in High Killip Grade AMI Patients. Journal of Cardiovascular Pharmacology and Therapeutics 2024; 29 doi: 10.1177/10742484241264673
|
| 79 |
Jun Wada, Hirofumi Makino. Inflammation and the pathogenesis of diabetic nephropathy. Clinical Science 2013; 124(3) doi: 10.1042/CS20120198
|
| 80 |
Wenyu Qin, Bao He, Yu Bei, Rushang Wang, Lang Feng, Youhua Xu, Jiaxiao Zhu, Zhaoguang Zheng, Quan Zhu, Hong Nie. Protective Effects of Danggui Buxue Tang on a Human Umbilical Vein Endothelialcell Damage Induced by Advanced Glycation End Products. Pharmacology & Pharmacy 2012; 3(02) doi: 10.4236/pp.2012.32030
|
| 81 |
Sheryar Afzal, Munavvar Abdul Sattar, Olorunfemi A. Eseyin, Ali Attiq, Edward James Johns. Crosstalk relationship between adiponectin receptors, PPAR-γ and α-adrenoceptors in renal vasculature of diabetic WKYs. European Journal of Pharmacology 2022; 917 doi: 10.1016/j.ejphar.2021.174703
|
| 82 |
Sepehr Safdel, Sara Assadiasl, Mahboobeh Freidoon, Hanieh Mojtahedi, Mahsa Gheitasi, Maryam Sadr, Hadi Kazemzadehghadim, Narjes Soleimanifar, Mohammad Hossein Nicknam. Endoplasmic reticulum aminopeptidase 1 gene expression and serum angiotensin II levels associated with developing nephropathy in type2 diabetes patients. Journal of Diabetes & Metabolic Disorders 2025; 24(2) doi: 10.1007/s40200-025-01772-9
|
| 83 |
Che-Hao Tseng, Kavya M. Shah, I-Jen Chiu, Li-Li Hsiao. The Role of Autophagy in Type 2 Diabetic Kidney Disease Management. Cells 2023; 12(23) doi: 10.3390/cells12232691
|
| 84 |
Devada Sindhu, Gaurav Shekhar Sharma, Damodar Kumbala. Management of diabetic kidney disease: where do we stand?: A narrative review. Medicine 2023; 102(13) doi: 10.1097/MD.0000000000033366
|
| 85 |
Chee Lee Wee, Ahmad Khusairi Azemi, Siti Safiah Mokhtar, Sahran Yahaya, Nik Soriani Yaacob, Aida Hanum Ghulam Rasool. Vitamin D deficiency enhances vascular oxidative stress, inflammation, and angiotensin II levels in the microcirculation of diabetic patients. Microvascular Research 2023; 150 doi: 10.1016/j.mvr.2023.104574
|
| 86 |
Chongyang Zhu, Wanxian Xu, Jingze Yang. Causal validation between 179 lipids and hyperparathyroidism: A bidirectional Mendelian randomization combined meta-analysis with mediation factors. Medicine 2025; 104(23) doi: 10.1097/MD.0000000000042580
|
| 87 |
Karthika Nellaiappan, Kumari Preeti, Dharmendra Kumar Khatri, Shashi Bala Singh. Diabetic Complications: An Update on Pathobiology and Therapeutic
Strategies. Current Diabetes Reviews 2022; 18(1) doi: 10.2174/1573399817666210309104203
|
| 88 |
Nimeet Desai, HariPriya Koppisetti, Shreya Pande, Havish Shukla, Bhagwat Sirsat, Aayushi S Ditani, Pragyan P Mallick, Umesh Kathar, Kiran Kalia, Rakesh K Tekade. Nanomedicine in the Treatment of Diabetic Nephropathy. Future Medicinal Chemistry 2021; 13(7) doi: 10.4155/fmc-2020-0335
|
| 89 |
Kiavash Hushmandi, Daniel J. Klionsky, Najma Farahani, Russel J. Reiter, Abbas Ali Imani Imani Fooladi, Mina Alimohammadi, Amir Reza Aref. Regulation of pyroptosis in diabetic nephropathy by long non-coding and circular RNAs. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01740-w
|
| 90 |
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds. The Natural Products Journal 2025; 15(7) doi: 10.2174/0122103155306808240705040740
|
| 91 |
Gnanaprakash Jeyaraj. Cardiovascular complications in Diabetes: The role of NLRP3 inflammasome and targeted interventions. Obesity Medicine 2025; 56 doi: 10.1016/j.obmed.2025.100629
|
| 92 |
Dolores Mino-León, Hortensia Reyes-Morales, Svetlana V. Doubova, Ricardo Pérez-Cuevas, Liliana Giraldo-Rodríguez, Marcela Agudelo-Botero. Multimorbidity Patterns in Older Adults: An Approach to the Complex Interrelationships Among Chronic Diseases. Archives of Medical Research 2017; 48(1) doi: 10.1016/j.arcmed.2017.03.001
|
| 93 |
Saxena Tarun, Khichi Garima, Saxena Ashutosh, Goyal Ramakant, Salem Nitasha. Diabetic Nephropathy – Pathophysiology: An Overview. Archives of Clinical Nephrology 2019; 5(1) doi: 10.17352/acn.000035
|
| 94 |
Joanna Szostak, Anna Gorący, Damian Durys, Paweł Dec, Andrzej Modrzejewski, Andrzej Pawlik. The Role of MicroRNA in the Pathogenesis of Diabetic Nephropathy. International Journal of Molecular Sciences 2023; 24(7) doi: 10.3390/ijms24076214
|
| 95 |
Paulo S. Caceres, Noreen F. Rossi. Comprehensive Toxicology. 2026; doi: 10.1016/B978-0-323-95488-4.00105-4
|
| 96 |
John P. Kirwan, Elizabeth C. Heintz, Candida J. Rebello, Christopher L. Axelrod. Comprehensive Physiology. 2023; doi: 10.1002/cphy.c220009
|
| 97 |
|
| 98 |
Fúlvia D. Marques, Marcos B. Melo, Leandro E. Souza, Maria Claúdia C. Irigoyen, Rúben D. Sinisterra, Frederico B. de Sousa, Sílvia Q. Savergnini, Vinícius B. A. Braga, Anderson J. Ferreira, Robson A. S. Santos, Mohan K. Raizada. Beneficial Effects of Long‐Term Administration of an Oral Formulation of Angiotensin‐(1–7) in Infarcted Rats. International Journal of Hypertension 2012; 2012(1) doi: 10.1155/2012/795452
|
| 99 |
Yuke Xie, Zhizhong Cui, Nan Wang, Peiluan Li. Research on Potential Network Markers and Signaling Pathways in Type 2 Diabetes Based on Conditional Cell-Specific Network. Genes 2022; 13(7) doi: 10.3390/genes13071155
|